IBMS/ECTS 2001 - PROGRAM and ABSTRACTS

SATELLITE SYMPOSIUM

OPTIMIZING THE TREATMENT OF OSTEOPOROSIS:
RECENT FINDINGS WITH RISEDRONATE

Sponsored by The Alliance for Better Bone Health - Procter & Gamble Pharmaceuticals and Aventis Pharma

Chairs: Aurelio Rapado (Madrid/Spain),
Pierre Meunier (Lyon/France)

Thursday, June 7, 2001
14:00 - 15:30 Auditorium

14:00
CHAIRMAN’S INTRODUCTORY COMMENTS
A. Rapado
Medicine Department/Metabolic Unit, Fundacion Jimenez Diaz, Madrid, Spain

14:10 - 15:00
RISEDRONATE’S FRACTURE BENEFIT - THE "WHOLE SKELETON" CONCEPT
REVIEW OF VERTEBRAL FRACTURE DATA
C. Cooper
MRC Environmental Epidemiology Unit, Southampton General Hospital, UK

REVIEW OF NON-VERTEBRAL FRACTURE DATA
M. R. McClung
Oregon Osteoporosis Centre, Portland, Oregon, USA

15:00
EXAMINING THE GI TOLERABILITY OF BISPHOSPHONATES
J. Marshall
Division of Gastroenterology, McMaster University Medical Centre, Hamilton, Ontario, Canada

15:20
CO-CHAIRMAN’S SUMMARY COMMENTS
P. J. Meunier
Edouard Herriot Hopital, Lyon, France

[Thursday at a Glance]  [Contents page]